130.01
前日終値:
$130.03
開ける:
$130.74
24時間の取引高:
5.19M
Relative Volume:
0.92
時価総額:
$200.04B
収益:
$43.84B
当期純損益:
$13.90B
株価収益率:
16.31
EPS:
7.9725
ネットキャッシュフロー:
$6.92B
1週間 パフォーマンス:
+2.53%
1か月 パフォーマンス:
+1.30%
6か月 パフォーマンス:
-3.41%
1年 パフォーマンス:
+10.95%
Abbott Laboratories Stock (ABT) Company Profile
名前
Abbott Laboratories
セクター
電話
(224) 667-6100
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ABT
Abbott Laboratories
|
130.01 | 226.11B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
359.60 | 137.72B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.82 | 123.49B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
BSX
Boston Scientific Corp
|
99.24 | 150.85B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
GEHC
Ge Healthcare Technologies Inc
|
71.02 | 32.17B | 20.25B | 2.29B | 1.40B | 4.8366 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | 開始されました | The Benchmark Company | Buy |
| 2025-07-18 | アップグレード | Jefferies | Hold → Buy |
| 2025-06-16 | 開始されました | Leerink Partners | Market Perform |
| 2024-10-08 | 開始されました | Oppenheimer | Outperform |
| 2024-09-19 | 開始されました | Piper Sandler | Overweight |
| 2024-07-30 | ダウングレード | Edward Jones | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-21 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 繰り返されました | Barclays | Overweight |
| 2023-04-20 | 繰り返されました | Bernstein | Outperform |
| 2023-04-20 | 繰り返されました | JP Morgan | Overweight |
| 2023-04-20 | 繰り返されました | Raymond James | Outperform |
| 2023-04-20 | 繰り返されました | UBS | Buy |
| 2023-04-20 | 繰り返されました | Wolfe Research | Underperform |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-10-26 | 開始されました | Mizuho | Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-27 | 繰り返されました | Credit Suisse | Outperform |
| 2022-01-27 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | UBS | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-27 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-01-28 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Outperform |
| 2020-06-01 | ダウングレード | Goldman | Neutral → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-02 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
| 2019-02-07 | 繰り返されました | BofA/Merrill | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-11-30 | アップグレード | Goldman | Neutral → Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-01-30 | 繰り返されました | Citigroup | Neutral |
| 2018-01-25 | 繰り返されました | Stifel | Buy |
| 2018-01-25 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-10-19 | 繰り返されました | Stifel | Buy |
すべてを表示
Abbott Laboratories (ABT) 最新ニュース
Abbott Laboratories (NYSE:ABT) jumps 3.3% this week, though earnings growth is still tracking behind three-year shareholder returns - Yahoo Finance
Businesses have slowed at making commitments – but Abbott Labs is still planning to build in BG - BG Independent News
AbbVie Stock Falls 4% -- What Investors Need to Know - The Motley Fool
Sentiment analysis tools applied to Abbott LaboratoriesJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Assessing Abbott Laboratories (ABT) Valuation Potential After Recent Share Price Momentum - simplywall.st
Will earnings trigger a reversal in Abbott LaboratoriesWatch List & Weekly Breakout Stock Alerts - newser.com
Will Abbott Laboratories (ABL) stock benefit from infrastructure billQuarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
Abbott Laboratories Stock: The Battle for the $140 Threshold - AD HOC NEWS
Can Abbott Laboratories stock surprise with earnings upsideBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Why Is Abbott (ABT) Up 1.3% Since Last Earnings Report? - Yahoo Finance
What Does the Market Think About Abbott Laboratories? - Benzinga
Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger - Yahoo Finance
Is Abbott Laboratories stock a buy on dipsMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com
New data backs Abbott Aveir dual-chamber leadless pacemaker system - MassDevice
Is Abbott Laboratories (Common Stock) (ABL0) stock a top dividend aristocrat candidateQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - newser.com
Here’s Why Abbott Laboratories (ABT) Traded Down in Q3 - Insider Monkey
Abbott Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
FDA expands urgent baby formula recall to all products made by one manufacturer - TheStreet
Citi Reaffirms Buy Rating on Abbott (ABT) Following Favorable Court Ruling - Insider Monkey
Abbott competitor's baby formula recalled after infant botulism outbreak - Crain's Chicago Business
Why pension funds invest in Abbott Laboratories (ABL) stockPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com
Unnatural Amino Acids Market to Reach US$ 5.03 Billion By 2032 Driven by Advances in Drug Discovery, Biologics and Protein Engineering - GlobeNewswire Inc.
A Look at Abbott Laboratories’s Valuation Following Revenue Growth and Maintained Outlook - Yahoo Finance
How Investors May Respond To Abbott (ABT) Missing Q3 Revenue Targets While Reaffirming Outlook and Buying Back Shares - Yahoo Finance
Why Abbott Laboratories (ABL) stock could be next leaderQuarterly Investment Review & Long-Term Safe Return Strategies - newser.com
Will a bounce in Abbott Laboratories offer an exit2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Will Recent Share Buybacks Reshape Abbott’s (ABT) Capital Allocation Story? - simplywall.st
Christine Poole's Top Picks: Abbott Labs, CN Rail & Otis Worldwide - BNN Bloomberg
Abbott Laboratories (ABT): Exploring Valuation After Mixed Q3 Earnings and Bullish Analyst Sentiment - simplywall.st
How Abbott Laboratories stock trades during market volatilityJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Will Abbott Laboratories (ABL) stock maintain strong growthJuly 2025 Setups & Weekly High Return Forecasts - newser.com
U.S. Functional Protein Market to Get an Explosive Growth| - openPR.com
Is a relief rally coming for Abbott Laboratories holdersWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Abbott Laboratories stock benefit from infrastructure spendingQuarterly Investment Review & Expert Approved Momentum Trade Ideas - fcp.pa.gov.br
Why Abbott Laboratories (Common Stock) (ABL0) stock is a must watch tickerMarket Activity Recap & AI Optimized Trade Strategies - newser.com
Has Abbott Stock’s Valuation Shifted With Expanded FDA Approvals in 2025? - Yahoo Finance
Why Abbott Laboratories (ABL) stock could outperform next yearQuarterly Trade Report & Expert Curated Trade Ideas - fcp.pa.gov.br
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Abbott Laboratories $ABT Stock Holdings Boosted by Dillon & Associates Inc. - MarketBeat
Tufton Capital Management Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Huntington National Bank Trims Holdings in Abbott Laboratories $ABT - MarketBeat
Commonwealth Retirement Investments LLC Acquires Shares of 20,274 Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories' (NYSE:ABT) Earnings Are Weaker Than They Seem - simplywall.st
Jacobson & Schmitt Advisors LLC Acquires Shares of 2,827 Abbott Laboratories $ABT - MarketBeat
Asia-Pacific Organic Baby Food Market Size and Share Analysis Report (2025-2033) Featuring Profiles of Key PlayersAbbott Labs, Nestle, Danone, Kewpie, and Hero Group Among Others - Yahoo Finance
Bank of New York Mellon Corp Cuts Position in Abbott Laboratories $ABT - MarketBeat
With 80% ownership, Abbott Laboratories (NYSE:ABT) boasts of strong institutional backing - Yahoo Finance
Freestone Capital Holdings LLC Cuts Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):